John Alter, PhD Pfizer

John is currently Vice President, Patient and Health Impact for Pfizer’s Hospital Business Unit, a $9 billion global business unit comprised of a well-balanced portfolio of differentiated and undifferentiated assets delivered across 10 therapeutic areas, with 50 molecules on the World Health Organization’s Essential Medicines List.

John has been with Pfizer for over 20 years in multiple roles of increasing responsibilities, the last five years with the Patient and Health Impact team. He has presented at several international conferences on the topic of pricing and access and in 2016 was a guest lecturer on the subject of HEOR at Kings College London as part of the International Federation of Association of Pharmaceutical Physicians.